Newsmeme!
Discover News you didn't know existed
Retinal Vessels
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
iCo Therapeutics Diabetic Macular Edema Clinical Trial Update
Published July 7, 2009, 6:00 am, CNW Group via Yahoo! Finance
iCo Therapeutics Inc. is pleased to report that the Safety Evaluation Committee for iCo's ongoing iCo-007 clinical trial has approved the advancement of the trial into the fourth and final cohort.
Phase III Study Showed Lucentis Improved Vision In Patients With Branch Retinal Vein Occlusion
Published July 7, 2009, 1:24 am, PharmaceuticalOnline
Genentech, Inc. announced recently that the Phase III study BRAVO showed Lucentis (ranibizumab injection) improved vision, as measured by the primary endpoint of mean change from baseline in best-corrected visual acuity at six months, in patients with macular edema due to branch retinal vein occlusion.
Phase III Study Showed Lucentis Improved Vision In Patients With Branch Retinal Vein Occlusion
Published July 6, 2009, 6:37 am, Medical News Today
Genentech, Inc. announced that the Phase III study BRAVO showed Lucentis® (ranibizumab injection) improved vision, as measured by the primary endpoint of mean change from baseline in best-corrected visual acuity at six months, in patients with macular edema due to branch retinal vein occlusion.
New laser eye surgery technique could prevent age-related sight loss
Published July 5, 2009, 3:27 pm, Times Online
New techniques in laser eye surgery could prevent millions of people from losing their sight, one of the country’s leading surgeons has said.
Hope for cure for blindness
Published July 5, 2009, 9:29 am, Daily Telegraph
Laser eye surgery pioneer has announced a new technique.
Phase III Study Showed Lucentis Improved Vision In Patients With Branch Retinal Vein Occlusion
Published July 4, 2009, 4:11 am, Medical News Today
Genentech, Inc. announced today that the Phase III study BRAVO showed Lucentis® (ranibizumab injection) improved vision, as measured by the primary endpoint of mean change from baseline in best-corrected visual acuity at six months, in patients with macular edema due to branch retinal vein occlusion.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |